Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-ranging trial of SABER-Bupivacaine for postoperative pain after arthroscopic shoulder surgery
2007-006122-96Phase 2Completed
- Sponsor
- Takeda
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Takeda. Primary endpoints: Primary efficacy variables, Pharmacokinetics and 1 more. Started Oct 2008; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2007-006122-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006122-96.